Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors (Q43435447)

23 November 2017

Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors (English)

1 reference

23 November 2017

0 references

Scott C Henderson

3

0 references

Helen L. Fillmore

object named as

Helen L Fillmore

1

0 references

author name string

Michael D Shultz

2

1 reference

23 November 2017

Patricia Cooper

4

1 reference

23 November 2017

William C Broaddus

5

1 reference

23 November 2017

Zhi Jian Chen

6

1 reference

23 November 2017

Chun-Ying Shu

7

1 reference

23 November 2017

Jianfei Zhang

8

1 reference

23 November 2017

Jiechao Ge

9

1 reference

23 November 2017

Harry C Dorn

10

1 reference

23 November 2017

Frank Corwin

11

1 reference

23 November 2017

Jerry I Hirsch

12

1 reference

23 November 2017

John Wilson

13

1 reference

23 November 2017

Panos P Fatouros

14

1 reference

23 November 2017

1 April 2011

1 reference

23 November 2017

1 reference

23 November 2017

6

1 reference

23 November 2017

3

1 reference

23 November 2017

449-458

1 reference

Applications of emerging molecular technologies in glioblastoma multiforme

23 November 2017

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Aggregation studies of the water-soluble gadofullerene magnetic resonance imaging contrast agent: [Gd@C82O6(OH)16(NHCH2CH2COOH)8]x

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Lanthanoid endohedral metallofullerenols for MRI contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Facile preparation of a new gadofullerene-based magnetic resonance imaging contrast agent with high 1H relaxivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Conjugation of a water-soluble gadolinium endohedral fulleride with an antibody as a magnetic resonance imaging contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Preparation and characterization of two new water-soluble endohedral metallofullerenes as magnetic resonance imaging contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Encapsulation of a radiolabeled cluster inside a fullerene cage, (177)Lu(x)Lu((3-x))N@C(80): an interleukin-13-conjugated radiolabeled metallofullerene platform

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Imaging immune response in vivo: cytolytic action of genetically altered T cells directed to glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

A realistic brain tissue phantom for intraparenchymal infusion studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

Erratum: Small-bandgap endohedral metallofullerenes in high yield and purity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.134

21 January 2018

Identifiers

DOI

10.2217/NNM.10.134

1 reference

23 November 2017

1 reference